Shanghai Shineyo Medical’s Cardiac PFA System Gains NMPA Approval, Expanding Atrial Fibrillation Treatment Options in China
On February 26, 2025, the SHINERHYTHM™ cardiac pulsed field ablation system and RHYTHPULSE™ single-use cardiac pulsed field ablation catheter developed by Shanghai Shineyo Medical Instrument...
Edge Medical Launches its CP1000 Robotic System in China, Revolutionising Thoracic Surgery
In a groundbreaking move to enhance precision and minimise patient trauma, Edge Medical, a Shenzhen-based innovative MedTech company, has unveiled its latest innovation in medical...
ECMO System from Hengrui Medical Has Gained NMPA Approval
Recently, Suzhou-based Hengrui Medical has announced its self-developed ECMO (Extracorporeal Membrane Oxygenation) system has been granted approval by the National Medical Products Administration (NMPA) in...
TeleLife (Anhui Tongling Bionics) Launches TL-IABP-100: A Game-Changer in Cardiovascular Care
On January 13, 2025, TeleLife (Anhui Tongling Bionics Technology Co., Ltd.) announced the launch of its TL-IABP-100, an advanced intra-aortic balloon pump (IABP) designed to address...
LoongCrystal®PR Type Intraocular Lens Receives the First Approval through NMPA’s Innovative Device Approval Channel in 2025
LoongCrystal®PR Type intraocular lens (IOL), developed by Eyebright Medical, has been approved for marketing by the National Medical Products Administration (NMPA) on January 6, 2025....